Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
Maria Kjærgaard(Odense University Hospital), Aleksander Krag(University of Southern Denmark), Peter Andersen(Odense University Hospital), Katrine Prier Lindvig(Odense University Hospital), Jørgen Ellegaard Andersen(University of Southern Denmark), Mads Israelsen(Odense University Hospital), Isabel Graupera(Hospital Clínic de Barcelona), Stine Johansen(University of Southern Denmark), Shan Shan(International Peace Maternity & Child Health Hospital), Johanne Kragh Hansen(Odense University Hospital), Nikolaj Torp(University of Southern Denmark), Maja Thiele(University of Southern Denmark), Pere Ginès(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Morten Beck Trelle(University of Southern Denmark), Nanna Kastrup(Aalborg University), Sönke Detlefsen(University of Southern Denmark), Jane Møller Jensen(Odense University Hospital), Camilla Dalby Hansen(University of Southern Denmark), Steen Antonsen(Odense University Hospital), Katrine Holtz Thorhauge(University of Southern Denmark)
Cited by 213
Related Papers
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
|Journal of Hepatology|2018|2.8k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Compensated cirrhosis: Natural history and prognostic factors
|Hepatology|1987|1.1k
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
|Ultraschall in der Medizin - European Journal of Ultrasound|2017|998